Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04468984
Brief Title: Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis (TRANSFORM-2)

First Submitted : July 10, 2020
First Submitted that Met QC Criteria : July 10, 2020
First Posted : July 13, 2020

Last Update Submitted that Met QC Criteria : October 14, 2021
Last Update Posted : October 18, 2021 (Estimate)